Delivery Order SPE2DB20D3103-SPE2DB24FP4F5
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The fixed-price delivery order has a ceiling value of $20,513.52 and a completion date of January 8, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract, valued at $13,703.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,852.98 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,837.84 and an ultimate completion date of December 18, 2024. It is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $61,796.23 and an ultimate completion date of February 29, 2024. The contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $17,697.50 and a completion date of December 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of Amerisourcebergen's broader $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $10,421.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, with a completion date of March 26, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $39,226.24 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 3, 2024 with an ultimate completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,974.55, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through March 5, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $22,017.22 and a completion date of February 13, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through...